Models of Aromatase Insufficiency

The recent studies on humans with a defective gene that encodes aromatase P450 (P450arom) and aromatase knockout (ArKO) mice with a disrupted P450arom gene uncovered many interesting aspects of physiology. Aromatase-deficient humans and ArKO mice continue to serve as invaluable models for us to study the roles of estrogen in normal and abnormal functions of several tissues. These roles will be discussed in detail in the following review article.

Aromatase deficiency - aromatase knockout mice - ArKO

REFERENCES

• 1 Shozu M, Akasofu K, Harada T, Kubota Y. A new cause of female pseudohermaphoditism: placental aromatase deficiency.  J Clin Endocrinol Metab. 1991;  72 560-566
• 2 Carani C, Qin K, Simoni M et al.. Aromatase deficiency in the male: effect of testosterone and estradiol treatment.  N Engl J Med. 1997;  337 91-95
• 3 Mullis P E, Yoshimura N, Kuhlmann B, Lippuner K, Jaeger P, Harada H. Aromatase deficiency in a female who is compound heterozygote for two new point mutations in the P450_arom gene: impact of estrogens on hypergonadotropic hypogonadism, multicystic ovaries, and bone densitometry in childhood.  J Clin Endocrinol Metab. 1997;  82 1739-1745
• 4 Ito Y, Fisher C R, Conte F A, Grumbach M M, Simpson E R. Molecular basis of aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries.  Proc Natl Acad Sci USA. 1993;  90 11673-11677
• 5 Conte F A, Grumbach M M, Ito Y, Fisher C R, Simpson E R. A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and mulicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom).  J Clin Endocrinol Metab. 1994;  78 1287-1292
• 6 Morishima A, Grumbach M M, Simpson E R, Fisher C, Qin M. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of oestrogens.  J Clin Endocrinol Metab. 1995;  80 3689-3698
• 7 Bilezikian J P, Morishima A, Bell J, Grumbach M M. Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency.  N Engl J Med. 1998;  339 599-603
• 8 Smith E P, Boyd J, Frank G R et al.. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man.  N Engl J Med. 1994;  331 1056-1061
• 9 Murata Y, Gong E, Clyne C. Point mutation in the CYP19 and its consequences (abstract). 83rd Meeting of the US Endocrine Society, June 25 2001 Denver, CO; Washington, DC; Endocrine Society
• 10 Hermann B L, Saller B, Janssen O E et al.. Impact of estrogen replacement therapy in a male with congenital aromatase deficiency caused by a novel mutation in the CYP19 gene.  J Clin Endocrinol Metab. 2002;  87 5476-5484
• 11 Pura M, Mittre H, Carreau S, Kottler M L. Clinical findings in an adult man with a novel mutation in the aromatase gene (abstract). 85th Meeting of the US Endocrine Society 2003 Denver, CO; Washington, DC; Endocrine Society
• 12 Fisher C R, Graves K H, Parlow A F, Simpson E R. Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene.  Proc Natl Acad Sci USA. 1998;  95 6965-6970
• 13 Honda S, Harada N, Takagi Y, Maeda S. Disruption of sexual behaviour in male aromatase-deficient mice lacking exons 1 and 2 of the cyp19 gene.  Biochem Biophys Res Commun. 1998;  252 445-449
• 14 Nemoto Y, Toda K, Ono M et al.. Altered expression of fatty acid metabolizing enzymes in aromatase-deficient mice.  J Clin Invest. 2000;  105 1819-1825
• 15 Toda K, Okada T, Akira S et al.. Oestrogen at the neonatal stage is critical for reproductive ability of male mice as revealed by supplementation with 17β-oestradiol to aromatase gene (cyp19) knockout mice.  J Endocrinol. 2001;  168 455-463
• 16 Robertson K, O'Donnell L, Jones M EE et al.. Impairment of spermatogenesis in mice lacking a functional aromatase (cyp 19) gene.  Proc Natl Acad Sci USA. 1999;  96 7986-7991
• 17 Robertson K M, Simpson E R, Lacham-Kaplan O, Jones M EE. Characterization of the fertility of the male aromatase knockout (ArKO) Mouse.  J Androl. 2001;  22 825-830
• 18 Eddy E M, Washburn T F, Bunch D O et al.. Targeted disruption of the oestrogen receptor gene in male mice causes alteration of spermatogenesis and infertility.  Endocrinology. 1996;  137 4796-4805
• 19 Nitta H, Bunick D, Hess R A et al.. Germ cells of the mouse testis express P450 aromatase.  Endocrinology. 1993;  132 1396-1401
• 20 Levallet J, Bilinska B, Mittre H, Genissel C, Fresnel J, Carreau S. Expression of immunolocalization of functional cytochrome P450 aromatase in mature rat testicular cells.  Biol Reprod. 1998;  58 919-926
• 21 Tsai-Morris C H, Aquilana D R, Dufau M L. Cellular localisation of rat testicular aromatase activity during development.  Endocrinology. 1985;  116 38-46
• 22 Janulis L, Bahr J M, Hess R A, Bunick D. P450 aromatase messenger ribonucleic acid expression in male rat germ cells: detection by reverse transcription-polymerase chain reaction amplification.  J Androl. 1996;  17 651-658
• 23 Simpson E R, Davis S R. Another role highlighted for estrogens in the male: sexual behaviour.  Proc Natl Acad Sci USA. 2000;  97 14038-14040
• 24 Ogawa S, Chester A E, Curtis Hewitt S et al.. Abolition of male sexual behaviours in mice lacking estrogen receptors α and β (αβERKO).  Proc Natl Acad Sci USA. 2000;  97 14737-14741
• 25 McPherson S J, Wang H, Jones M E et al.. Elevated androgens and prolactin in aromatase deficient mice (ArKO) cause enlargement but not malignancy of the prostate gland.  Endocrinology. 2001;  142 2458-2467
• 26 Weihua Z, Makela S, Andersson L C et al.. A role for estrogen receptor β in the regulation of growth of the ventral prostate.  Proc Natl Acad Sci USA. 2001;  98 6330-6335
• 27 Britt K L, Drummond A E, Cox V A et al.. An age-related ovarian phenotype in mice with targeted disruption of the cyp19 (aromatase) gene.  Endocrinology. 2000;  141 2614-2623
• 28 Jones M EE, Thorburn A W, Britt K L et al.. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity.  Proc Natl Acad Sci USA. 2000;  97 12735-12740
• 29 Jones M EE, Thorburn A W, Britt K L et al.. The obese phenotype of the ArKO mouse.  J Steroid Biochem Mol Biol. 2001;  79 3-9
• 30 Farooqi I S, Jebb S A, Langmack G et al.. Effects of recombinant leptin therapy in a child with cogenital leptin deficiency.  N Engl J Med. 1999;  341 879-915
• 31 Heine P A, Taylor J A, Iwamoto G A, Lubahn D B, Cooke P S. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice.  Proc Natl Acad Sci USA. 2000;  97 12729-12734
• 32 Nemoto Y, Toda K, Ono M et al.. Altered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice.  J Clin Invest. 2000;  105 1819-1825
• 33 Oz O, Zerwekh J E, Fisher C et al.. Bone has a sexually dimorphic response to aromatase deficiency.  J Bone Miner Res. 2000;  15 507-514